Glenmede Trust’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-348
Closed -$3K 2494
2018
Q1
$3K Hold
348
﹤0.01% 2557
2017
Q4
$3K Hold
348
﹤0.01% 2557
2017
Q3
$2K Hold
348
﹤0.01% 2622
2017
Q2
$2K Hold
348
﹤0.01% 2541
2017
Q1
$2K Buy
348
+248
+248% +$1.94K ﹤0.01% 2541
2016
Q4
$0 Sell
100
-47
-32% -$386 ﹤0.01% 2708
2016
Q3
$1K Hold
147
﹤0.01% 2537
2016
Q2
$1K Sell
147
-527
-78% -$6.6K ﹤0.01% 2509
2016
Q1
$7K Buy
674
+281
+72% +$2.91K ﹤0.01% 2149
2015
Q4
$3K Sell
393
-273
-41% -$3.53K ﹤0.01% 2415
2015
Q3
$9K Buy
666
+127
+24% +$2.57K ﹤0.01% 2151
2015
Q2
$10K Buy
539
+190
+54% +$4.35K ﹤0.01% 2112
2015
Q1
$8K Buy
+349
New +$7.08K ﹤0.01% 2178
2014
Q1
Sell
-232
Closed -$4K 2416
2013
Q4
$4K Buy
+232
New +$3.74K ﹤0.01% 2158

Other funds holding KND

Glenmede Trust's KND Position: Q2 2018 in Review

Glenmede Trust sold out of Kindred Healthcare (KND) in Q2 2018, closing a stake of 348 shares — an estimated $3K sold.

Glenmede Trust first reported a position in KND in Q4 2013 and held it in 14 quarters. The position peaked at $10K in Q2 2015. 149 funds tracked by Wall St. Rank hold KND as of Q2 2018.

  • Glenmede Trust reported no remaining Kindred Healthcare position as of Q2 2018 after selling out during the quarter.
  • Glenmede Trust sold 348 Kindred Healthcare shares in Q2 2018, an estimated $3K.
  • Glenmede Trust first reported a position in Kindred Healthcare in Q4 2013 and held it in 14 quarters.
  • Glenmede Trust's Kindred Healthcare position peaked at $10K in Q2 2015.
  • 149 funds tracked by Wall St. Rank held Kindred Healthcare as of Q2 2018.

Based on Glenmede Trust's 13F filing for Q2 2018, filed 15 Aug 2018.